OptumRx is under investigation by Congress for tactics that are harming patient care and increasing costs for consumers
https://oversight.house.gov/release/comer-launches-investigation-into-pharmacy-benefit-managers-role-in-rising-health-care-costs%EF%BF%BC/
LCRA advises pharmacy so what the heck were they doing……..nothing
FTC launches investigation into major pharmacy benefit managers' business practices
https://www.fiercehealthcare.com/payers/ftc-launches-investigation-major-pharmacy-benefit-managers-business-practices
Please read this
https://oversight.house.gov/release/comer-releases-report-on-pbms-tactics-leading-to-soaring-prescription-dr-g-prices/
https://oversight.house.gov/release/comer-launches-investigation-into-pharmacy-benefit-managers-role-in-rising-health-care-costs%EF%BF%BC/
According to this article, Congress launched an investigation into pharmacy benefit managers’ (PBM) tactics that are harming patient care and increasing costs for consumers.
As part of this investigation, Congress ordered companies, including OptumRx, to provide numerous documents.
According to this letter, “Pharmacy Benefit Managers’ anticompetitive tactics are driving up health care costs for Americans and harming patient care”
Please review this letter for the specifics
https://oversight.house.gov/wp-content/uploads/2023/03/Letter-to-Optum-Rx.pdf